WLF: Courts Need to Put Teeth Into Securities Reform Law
By Mari Serebrov
Tuesday, July 9, 2013
If an appellate court allows a shareholder suit alleging fraud to proceed against Genzyme Corp., it will encourage more such frivolous lawsuits to be filed against drugmakers, a public interest law and policy center said in filing an amicus brief this week on behalf of Genzyme.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.